Literature DB >> 31467078

APC ameliorates pulmonary complications in cGVHD.

Vahid Afshar-Kharghan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31467078      PMCID： PMC6716073          DOI： 10.1182/blood.2019002182

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans.

Authors:  Mathangi Srinivasan; Ryan Flynn; Andrew Price; Ann Ranger; Jeffrey L Browning; Patricia A Taylor; Jerome Ritz; Joseph H Antin; William J Murphy; Leo Luznik; Mark J Shlomchik; Angela Panoskaltsis-Mortari; Bruce R Blazar
Journal:  Blood       Date:  2011-11-09       Impact factor: 22.113

Review 2.  Activated protein C: biased for translation.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

Review 3.  Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway.

Authors:  E A M Bouwens; F Stavenuiter; L O Mosnier
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

Review 4.  Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets.

Authors:  Robert Zeiser; Bruce R Blazar
Journal:  N Engl J Med       Date:  2017-12-28       Impact factor: 91.245

5.  Activated protein C ameliorates chronic graft-versus-host disease by PAR1-dependent biased cell signaling on T cells.

Authors:  Ranjeet K Sinha; Ryan Flynn; Michael Zaiken; Katelyn Paz; Amanda L Gavin; David Nemazee; José A Fernández; Xiao Xu; John H Griffin; Bruce R Blazar
Journal:  Blood       Date:  2019-06-26       Impact factor: 22.113

Review 6.  Chronic graft-versus-host disease: biological insights from preclinical and clinical studies.

Authors:  Kelli P A MacDonald; Geoffrey R Hill; Bruce R Blazar
Journal:  Blood       Date:  2016-11-07       Impact factor: 22.113

7.  Circulating T follicular helper cells with increased function during chronic graft-versus-host disease.

Authors:  Edouard Forcade; Haesook T Kim; Corey Cutler; Kathy Wang; Ana C Alho; Sarah Nikiforow; Vincent T Ho; John Koreth; Philippe Armand; Edwin P Alyea; Bruce R Blazar; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2016-03-04       Impact factor: 22.113

8.  Thrombomodulin alleviates murine GVHD in association with an increase in the proportion of regulatory T cells in the spleen.

Authors:  T Ikezoe; J Yang; C Nishioka; A Yokoyama
Journal:  Bone Marrow Transplant       Date:  2014-09-22       Impact factor: 5.483

9.  Activated protein C protects from GvHD via PAR2/PAR3 signalling in regulatory T-cells.

Authors:  Satish Ranjan; Alexander Goihl; Shrey Kohli; Ihsan Gadi; Mandy Pierau; Khurrum Shahzad; Dheerendra Gupta; Fabian Bock; Hongjie Wang; Haroon Shaikh; Thilo Kähne; Dirk Reinhold; Ute Bank; Ana C Zenclussen; Jana Niemz; Tina M Schnöder; Monika Brunner-Weinzierl; Thomas Fischer; Thomas Kalinski; Burkhart Schraven; Thomas Luft; Jochen Huehn; Michael Naumann; Florian H Heidel; Berend Isermann
Journal:  Nat Commun       Date:  2017-08-21       Impact factor: 14.919

Review 10.  Activated protein C, protease activated receptor 1, and neuroprotection.

Authors:  John H Griffin; Berislav V Zlokovic; Laurent O Mosnier
Journal:  Blood       Date:  2018-06-04       Impact factor: 25.476
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.